Dexu Ren

FBXO2 targets glycosylated SUN2 for ubiquitination and degradation to promote ovarian cancer development

Mengru Xie, W. Shi, Jing Shen, 2022, Cell Death & Disease.

VHL-HIF-2α axis-induced SEMA6A upregulation stabilized β-catenin to drive clear cell renal cell carcinoma progression

Zefeng Chen, Mengru Xie, Zhichao Sun, 2023, Cell Death & Disease.

Identification of the deubiquitinase USP28 as a novel molecular therapeutic target of ovarian cancer.

Mengru Xie, Jinling Huang, Jing Ji, 2022, Biochemical and biophysical research communications.

Epigenetic reactivation of PEG3 by EZH2 inhibitors suppresses renal clear cell carcinoma progress.

Guanchu Li, Mengru Xie, Jing Ji, 2023, Cellular signalling.

The atypical ubiquitin ligase RNF31 stabilizes c-Myc via epigenetic inactivation of FBXO32 nd promotes cancer development.

Zefeng Chen, Mengru Xie, Shunfang Liu, 2023, Cellular signalling.

SOX9-mediated UGT8 expression promotes glycolysis and maintains the malignancy of non-small cell lung cancer.

Jing Ji, Bin Liu, Yuxin Xu, 2021, Biochemical and biophysical research communications.